Brief: Pharmacorp Rx Inc. Announces Second Quarter 2026 Financial Results
20/08/2026 12:36
BRIEF-Pharmacorp Rx Inc. Announces Second Quarter 2026 Financial Results PharmaCorp Rx Inc PCRX.V:
PHARMACORP RX INC. ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS
PHARMACORP RX - Q2 2026 REVENUE $7.7 MILLION VERSUS $4.4 MILLION IN Q2 2025
PHARMACORP RX - Q2 2026 SAME-STORE SALES UP 3.8%, SAME-STORE PRESCRIPTION SALES UP 5.2% YEAR-OVER-YEAR
Source text: ID:nGNXbsPFdT
Further company coverage: PCRX.V
Recent news on PharmaCorp Rx
See all newsBrief: PharmaCorp Closes Two Previously Announced Acquisitions And Provides Acquisition Pipeline Update
Brief: Pharmacorp Rx Inc. Announces Second Quarter 2026 Financial Results
Brief: PharmaCorp To Acquire Eight Pharmacies For $24.2 Million
Brief: Pharmacorp Announces C$15 Million Bought Deal Public Offering
Brief: Pharmacorp Rx Inc Files Final Base Shelf Prospectus